Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
Main Authors: | Bhattacharya, Amal, Bhargava, Salil, Singh, Virendra, Talwar, Deepak, Whig, Jagdeep, Rebello, Juliet, Purandare, Shrinivas, Gogtay, Jaideep |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934560/ |
Similar Items
-
Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
by: De Backer, LA, et al.
Published: (2011) -
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
by: Haney, Sarah, et al.
Published: (2007) -
Airway hygiene in the ICU: can ipratropium plus salbutamol help?
by: Magalhaes, N
Published: (2015) -
Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient
by: Santana-Cabrera, Luciano, et al.
Published: (2012) -
Formulation and Development of Metered Dose Inhalations of Salbutamol in Solution Form
by: Khale, Anubha, et al.
Published: (2011)